Explore the revamped online webpage of Functional Genomics South Australia Core Facility (FGSA), formerly known as the Gene Silencing and Expression facility.
Supported by Phenomics Australia at the University of Adelaide, FGSA offers cutting-edge gene manipulation, high throughput assay services, and comprehensive cell line testing, all within a fully equipped PC2 laboratory.
As an integral node of Phenomics Australia, FGSA operates on a researcher-driven model. Researchers are seamlessly integrated into the facility, receiving training on advanced appropriate equipment and support from concept design to screening and analysis.
FGSA specializes in the production of lentiviral, AAV, and retroviral vectors. Read more about their services here.
Need a different viral system? Reach out to FGSA for personalized consultation and expert guidance.
For inquiries about the FGSA Core Facility, contact Dr Jason Gummow. Phenomics Australia’s Scientific Director Prof. Simon Barry, is also available for technical consulting.
Contact FGSA now to explore their capabilities, discuss custom projects, and inquire about pricing options.
Through the Victorian Centre for Functional Genomics (VCFG) at the Peter MacCallum Cancer Centre, the Harry Perkins Institute of Medical Research (Perkins), the ANU Centre for Therapeutic Discovery (ACTD, The John Curtin School of Medical Research, ANU), the Monash Functional Genomics Platform (MFGP) at Monash University, and the Functional Genomics South Australia (FGSA) at the University of Adelaide (in partnership with SAHMRI), Phenomics Australia Functional Genomics and High-throughput screening services enable biomedical researchers Australia-wide with the ability to perform novel discovery-based screens using multiple platforms.
